PLA2R1 and glomerular disorder: Thus TWEAK increases PLA2R expression in human podocytes, a response prevented by tacrolimus [11], while IL-17 drives the formation of kidney tertiary lymphoid organs in primary glomerular disease, a feature associated with high circulating CXCL13 levels [40].